1. Home
  2. AADI vs CNVS Comparison

AADI vs CNVS Comparison

Compare AADI & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • CNVS
  • Stock Information
  • Founded
  • AADI 2011
  • CNVS 2000
  • Country
  • AADI United States
  • CNVS United States
  • Employees
  • AADI N/A
  • CNVS N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • CNVS Consumer Electronics/Video Chains
  • Sector
  • AADI Health Care
  • CNVS Consumer Discretionary
  • Exchange
  • AADI Nasdaq
  • CNVS Nasdaq
  • Market Cap
  • AADI 59.4M
  • CNVS 56.2M
  • IPO Year
  • AADI N/A
  • CNVS 2003
  • Fundamental
  • Price
  • AADI $2.98
  • CNVS $3.54
  • Analyst Decision
  • AADI Hold
  • CNVS Buy
  • Analyst Count
  • AADI 3
  • CNVS 1
  • Target Price
  • AADI $1.75
  • CNVS $10.00
  • AVG Volume (30 Days)
  • AADI 863.3K
  • CNVS 104.5K
  • Earning Date
  • AADI 03-12-2025
  • CNVS 02-12-2025
  • Dividend Yield
  • AADI N/A
  • CNVS N/A
  • EPS Growth
  • AADI N/A
  • CNVS N/A
  • EPS
  • AADI N/A
  • CNVS N/A
  • Revenue
  • AADI $25,070,000.00
  • CNVS $45,005,000.00
  • Revenue This Year
  • AADI $8.43
  • CNVS $50.96
  • Revenue Next Year
  • AADI $5.41
  • CNVS N/A
  • P/E Ratio
  • AADI N/A
  • CNVS N/A
  • Revenue Growth
  • AADI 7.80
  • CNVS N/A
  • 52 Week Low
  • AADI $1.21
  • CNVS $0.72
  • 52 Week High
  • AADI $3.81
  • CNVS $4.19
  • Technical
  • Relative Strength Index (RSI)
  • AADI 50.12
  • CNVS 49.00
  • Support Level
  • AADI $2.91
  • CNVS $3.34
  • Resistance Level
  • AADI $3.27
  • CNVS $3.60
  • Average True Range (ATR)
  • AADI 0.27
  • CNVS 0.23
  • MACD
  • AADI -0.06
  • CNVS -0.05
  • Stochastic Oscillator
  • AADI 11.68
  • CNVS 28.57

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Share on Social Networks: